PCOS和非PCOS克罗米芬抗药患者的克罗米芬-地塞米松治疗

来源 :国外医学.妇产科学分册 | 被引量 : 0次 | 上传用户:melancholy111
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
下丘脑垂体卵巢轴功能障碍导致的慢性排卵停止是不孕症的主要原因之一。近来一些学者提出大剂量克罗米芬(CC)与皮质激素如地塞米松、强地松或强地松龙联合用药的治疗方案,并认为以高雄激素血症和多囊卵巢综合征(PCOS)为首选。40例单独应用大剂量 CC 及 hCG 或不用 hCG 治疗失败的不孕症患者为试验对象。治疗前常规行各项不孕症检查以排除输卵管疾患,盆腔粘连、子宫 Hypothalamic pituitary ovarian axis dysfunction caused by chronic ovulation stop infertility is one of the main reasons. Recently, some scholars have proposed a combination of high-dose clomiphene citrate (CC) and corticosteroids such as dexamethasone, prednisone or prednisolone combination therapy and that with hyperandrogenism and polycystic ovary syndrome (PCOS) as Preferred. Forty patients with infertility who were treated with high-dose CC and hCG alone or without hCG were selected as subjects. Routines routine treatment of infertility check to exclude tubal disease, pelvic adhesions, uterus
其他文献
本文报道268例子宫肌瘤患者,均已婚,年龄25~57岁。其中原发不孕12例,按月经周期,用四种维生素治疗,共用药1573个周期,人均治病5.87个周期,子宫肌瘤大小以B超测量子宫长、横、
本文通过250例孕妇血清及250例新生儿脐血清经捕获法-EIA 检测风疹病毒特异性抗体(RV-IgM),结果:孕妇 RV 感染率为3.6%(9/250),婴儿先天性 RV 感染率为2.8%(7/250)。9例孕妇
【正】 On March 3rd, PetroChina Company Ltd.signed a strategic cooperation frameworkagreement with China Coal Energy Company Limited (ChinaCoal) in Beijing.Unde
作者用放射免疫法测定了34例人工流产术后子宫粘连(IUA)者血清保卵泡刺激素、促黄体生长素、泌乳素、雌二醇和孕酮,并与34例人工流产术后无子宫粘连者比较。结果显示:子宫粘
China’s petroleum and chemical industry isestimated to remain double-digit growth by2015.Forecasts for different segments arelisted below:1.RefiningIt is esti
协作组会议于1982年2月中旬在北京召开。会议认为,1979年兰州会议,对各地糖尿病研究工作的开展起了积极的推动作用,主要表现在:完成了全国14个省市总计30万人以上糖尿病患病
CNOOC Limited plans a total capital expenditureof US$7.93 billion in production growth and intensiveexploration program for 2010,representingan increase of 29.5
卵巢非赘生性囊肿是一种良性潴留性囊肿(r t ntion cyst),是由于生理或病理的原因,于卵巢囊腔内有液体潴留,囊腔渐大,当腔内压达到一定程度后,囊腔壁的细胞萎缩,囊液分泌停
我们自1987~1989年共诊治多囊卵巢综合征(PCOS)患者167例。其中以不孕、不育为主诉者160例。经以氯米酚为主的各种不同的联合用药促排卵治疗后,妊娠者112例,现将其临床表现、
We report a synthetic design and the experimental exploration of preparation of disubstituted polyacetylenes(PAs,P3) through 1,3-dipolar cycloaddition of azides